C stock · XTNT stock

C vs XTNT · P/E 16, rev $85.22B vs rev $133.9M

Citigroup Inc. (C) versus Xtant Medical Holdings Inc (XTNT) — a side-by-side from cached financials, not a winner call.

Citigroup Inc. (C) is a banks - diversified company listed on US.

Xtant Medical Holdings Inc (XTNT) is a medical devices company listed on US.

Latest reported C revenue for 2025-12-31 was $85.22B. Net income was $14.31B. Revenue was up 5.0% from 2024-12-31 to 2025-12-31. C currently screens at market cap $214.73B and trailing P/E 15.5.

Latest reported XTNT revenue for 2025-12-31 was $133.9M. Net income was $5.0M. Revenue was up 14.2% from 2024-12-31 to 2025-12-31. XTNT currently screens at market cap $91.0M.

C currently screens at market cap $214.73B and trailing P/E 15.5. XTNT currently screens at market cap $91.0M.

Not investment advice. Open the C and XTNT stock pages for the full models.

Not investment advice.

Popular Stock Comparisons